Contraception Clinical Trial
Official title:
Essure Permanent Birth Control, Effectiveness and Safety: A French Survey
Since 2002, in CHU Amiens, Essure implants started to be used for women in need of voluntary
sterilization in accordance with French national recommendations. Recently patient committees
emerged to alert health agency and governments about various symptoms possibly link to the
Essure implants. New studies have been launched in order to determinate if Essure implants
were involved with the symptoms described. According to the scientific literature no solid
link between Essure and the symptomatology was highlighted. French National College of
Gynecologists and Obstetricians send a letter of information for patient and gynecologists.
French National agency of medicament suspended Essure authorization in august 2017 for 3
months. Bayer industry decided to withdraw from the market the Essure implants in autumn
2017. Currently Essure procedures have been stopped to be used in CHU Amiens since august
2017. But, in CHU Amiens, health institutions still have to manage patients with Essure
implants and potential adverse effects.
The purpose of this study is to determine if the patients treated between 2002 and 2017 with
Essure implant present complications, had a proper follow up after the Essure implantation,
and that the Essure implantation respected the medical guidelines in order to offer the best
medical care with these new informations.
Medical data from patients who received Essure procedure will be collected with medical file
and a survey about adverse effects will be submitted to patients by phone if they agree to
take part of the study after loyal information.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
| Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
| Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
| Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
| Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
| Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
| Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
| Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
| Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
| Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
| Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
| Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
| Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
| Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
| Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
| Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
| Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |